Rapid adipose deposition with mood disorders
- PMID: 26554369
- PMCID: PMC4696501
Rapid adipose deposition with mood disorders
Abstract
Background: Persons with bipolar disorder represent a high-risk group for obesity, but little is known about the time course by which weight gain occurs in bipolar disorder.
Methods: We prospectively studied changes in fat distribution using dual-energy x-ray absorptiometry in relationship to medication exposure and mood symptom burden in 36 participants with bipolar disorder. We assessed the relationship between prior medication exposure and course of illness with adiposity measures at baseline (N = 36) and at 6-month follow-up (N = 22).
Results: At baseline, greater adiposity was associated with advanced age and female sex, not retrospectively assessed symptom course or medication exposure (past 2 years). Over 6 months of prospective follow-up, participants developed greater adiposity (fat mass index +0.82 kg/m(²), P = .007; visceral fat area +8.6 cm(²), P = .02; total percent fat +1.6%, P = .02). Manic symptomatology, not antipsychotic exposure, was related to the increased adiposity.
Conclusions: Acute exacerbations of mood disorders appear to represent high-risk periods for adipose deposition. Obesity prevention efforts may be necessary during acute exacerbations.
Figures
 
              
              
              
              
                
                
                References
- 
    - Shah A, Shen N, El-Mallakh RS. Weight gain occurs after onset of bipolar illness in overweight bipolar patients. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists. 2006 Oct-Dec;18(4):239–241. - PubMed
 
- 
    - Fiedorowicz JG, Palagummi NM, Forman-Hoffman VL, Miller DD, Haynes WG. Elevated prevalence of obesity, metabolic syndrome, and cardiovascular risk factors in bipolar disorder. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists. 2008 Jul-Sep;20(3):131–137. - PMC - PubMed
 
- 
    - Liu CS, Carvalho AF, Mansur RB, McIntyre RS. Obesity and bipolar disorder: synergistic neurotoxic effects? Advances in therapy. 2013 Nov;30(11):987–1006. - PubMed
 
- 
    - Gilles M, Hentschel F, Paslakis G, Glahn V, Lederbogen F, Deuschle M. Visceral and subcutaneous fat in patients treated with olanzapine: a case series. Clinical neuropharmacology. 2010 Sep-Oct;33(5):248–249. - PubMed
 
 
        